New study aims to unlock mysteries of rare thyroid condition
NCT ID NCT06307990
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This observational study will enroll 150 people to better understand thyroid hormone resistance syndromes, rare conditions where the body does not respond properly to thyroid hormone. Researchers will use genetic testing, blood analysis, and lab-grown cells to find better ways to diagnose and monitor these syndromes. The study does not test any new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could improve early diagnosis and monitoring tools for rare thyroid hormone resistance syndromes.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly benefit participants and may not lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESISTANCE TO THYROID HORMONE ALPHA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Endocrine & Metabolic Diseases, San Luca Hospital
RECRUITINGMilan, Italy
-
Istituto Auxologico Italiano IRCCS
RECRUITINGMilan, 20145, Italy